N-terminally truncated C protein, CNΔ25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication

Virology

Volumn 394, Issue 1, 2009, Pages 143-148

  Mao, Hongxia ^a   Chattopadhyay, Santanu ^a   Banerjee, Amiya K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antivirals; C protein; CN 25 protein; HPIV3

Indexed keywords

AMINO ACID; AMINO TERMINALLY TRUNCATED C PROTEIN DELTA 25; INTERFERON; PROTEIN C; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG MECHANISM; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA SYNTHESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANTIVIRAL AGENTS; HELA CELLS; HUMANS; MUTANT PROTEINS; PARAINFLUENZA VIRUS 3, HUMAN; RESPIRATORY SYNCYTIAL VIRUSES; RNA, VIRAL; SEQUENCE DELETION; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN PARAINFLUENZA VIRUS 3; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 70350128823     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.026     Document Type: Article

References (31)

1. Chattopadhyay S., and Banerjee A.K. Phosphoprotein, P of human parainfluenza virus type 3 prevents self-association of RNA-dependent RNA polymerase, L. Virology 383 2 (2009) 226-236
2. Cortez K.J., Erdman D.D., Peret T.C., Gill V.J., Childs R., Barrett A.J., and Bennett J.E. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J. Infect. Dis. 184 9 (2001) 1093-1097
3. Durbin A.P., McAuliffe J.M., Collins P.L., and Murphy B.R. Mutations in the C, D and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 261 2 (1999) 319-330
4. Escoffier C., Manié S., Vincent S., Muller C.P., Billeter M., and Gerlier D. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73 2 (1999) 1695-1698
5. Galinski M.S., Troy R.M., and Banerjee A.K. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology 186 2 (1992) 543-550
6. Grogan C.C., and Moyer S.A. Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis. Virology 288 1 (2001) 96-108
7. Hallak, L.K., Collins, P.L., Knudson, W., Peeples, M.E., 2000. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271, 264-275.
8. Hasan M.K., Kato A., Muranaka M., Yamaguchi R., Sakai Y., Hatano I., Tashiro M., and Nagai Y. Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. J. Virol. 74 12 (2000) 5619-5628
9. Hoffman M.A., and Banerjee A.K. Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology 269 1 (2000) 201-211
10. Horikami S.M., Hector R.E., Smallwood S., and Moyer S.A. The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology 235 2 (1997) 261-270
11. Kato A., Ohnishi Y., Kohase M., Saito S., Tashiro M., and Nagai Y. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75 8 (2001) 3802-3810
12. Kato A., Ohnishi Y., Hishiyama M., Kohase M., Saito S., Tashiro M., and Nagai Y. The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J. Virol. 76 14 (2002) 7114-7124
13. Kato A., Cortese-Grogan C., Moyer S.A., Sugahara F., Sakaguchi T., Kubota T., Otsuki N., Kohase M., Tashiro M., and Nagai Y. Characterization of the amino acid residues of Sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J. Virol. 78 14 (2004) 7443-7454
14. Kato A., Kiyotani K., Kubota T., Yoshida T., Tashiro M., and Nagai Y. Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J. Virol. 81 7 (2007) 3264-3271
15. Koyama A.H., Irie H., Kato A., Nagai Y., and Adachi A. Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Microbes Infect. 5 5 (2003) 373-378
16. Kurotani A., Kiyotani K., Kato A., Shioda T., Sakai Y., Mizumoto K., Yoshida T., and Nagai Y. Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells 3 2 (1998) 111-124
17. Liuzzi M., Mason S.W., Cartier M., Lawetz C., McCollum R.S., Dansereau N., Bolger G., Lapeyre N., Gaudette Y., Lagacé L., Massariol M.J., Dô F., Whitehead P., Lamarre L., Scouten E., Bordeleau J., Landry S., Rancourt J., Fazal G., and Simoneau B. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J. Virol. 79 20 (2005) 13105-13115
18. Lo M.K., Harcourt B.H., Mungall B.A., Tamin A., Peeples M.E., Bellini W.J., and Rota P.A. Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells. J. Gen. Virol. 90 Pt. 2 (2009) 398-404
19. Madhi S.A., Ramasamy N., Petersen K., Madhi A., and Klugman K.P. Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1. Eur. J. Clin. Microbiol. Infect. Dis. 21 7 (2002) 499-505
20. Malur A.G., Hoffman M.A., and Banerjee A.K. The human parainfluenza virus type 3 (HPIV3) C protein inhibits viral transcription. Virus Res. 99 2 (2004) 199-204
21. Malur A.G., Chattopadhyay S., Maitra R.K., and Banerjee A.K. Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein. J. Virol. 79 12 (2005) 7877-7882
22. Mao H., Thakur C.S., Chattopadhyay S., Silverman R.H., Gudkov A., and Banerjee A.K. Inhibition of human parainfluenza virus type 3 infection by novel small molecules. Antivir. Res. 77 2 (2008) 83-94
23. Nakatsu Y., Takeda M., Ohno S., Koga R., and Yanagi Y. Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J. Virol. 80 23 (2006) 11861-11867
24. Nakatsu Y., Takeda M., Ohno S., Shirogane Y., Iwasaki M., and Yanagi Y. Measles virus circumvents the host interferon response by different actions of the C and V proteins. J. Virol. 82 17 (2008) 8296-8306
25. Nichols W.G., Peck Campbell A.J., and Boeckh M. Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin. Microbiol. Rev. 21 2 (2008) 274-290
26. Nokes J.D., and Cane P.A. New strategies for control of respiratory syncytial virus infection. Curr. Opin. Infect. Dis. 21 6 (2008) 639-643
27. Sakaguchi T., Kato A., Sugahara F., Shimazu Y., Inoue M., Kiyotani K., Nagai Y., and Yoshida T. AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J. Virol. 79 14 (2005) 8933-8941
28. Sato M., and Wright P.F. Current status of vaccines for parainfluenza virus infections. Pediatr. Infect. Dis. J. 27 10 Suppl. (2008) S123-S125
29. Sleeman K., Bankamp B., Hummel K.B., Lo M.K., Bellini W.J., and Rota P.A. The C, V and W proteins of Nipah virus inhibit minigenome replication. J. Gen. Virol. 89 Pt. 5 (2008) 1300-1308
30. Toth A.M., Devaux P., Cattaneo R., and Samuel C.E. Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus. J. Virol. 83 2 (2009) 961-968
31. Wells G., and Malur A. Expression of human parainfluenza virus type 3 PD protein and intracellular localization in virus infected cells. Virus Genes 37 3 (2008) 358-367